Literature DB >> 16770730

Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis.

Ewa Usarek1, Magdalena Kuźma-Kozakiewicz, Birgit Schwalenstöcker, Beata Kaźmierczak, Christoph Münch, Albert C Ludolph, Anna Barańczyk-Kuźma.   

Abstract

Tau is a protein involved in regulation of microtubule stability, axonal differentiation and transport. Alteration of retrograde transport may lead to motor neuron degeneration. Thus alternative mRNA splicing and expression of tau isoforms were studied in a transgenic mouse model harboring the human SOD1 G93A mutation. The studies were performed on cortex, hippocampus and spinal cord of 64- and 120-day-old animals (presymptomatic and symptomatic stage) and wild type controls. Exon 10 was found in all studied tissues. The 2N isoform containing exons 2 and 3 (+2+3) and the 1N (+2-3) predominated over the 0N (-2-3) in brain regions of the studied mice. The 2N expression was significantly lower in cortex and hippocampus of symptomatic animals compared to analogue control tissues. The decrease in 2N expression resulted in lower levels of total tau mRNA and tau protein. No changes in tau expression were observed in spinal cord of studied animals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770730     DOI: 10.1007/s11064-006-9057-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

2.  A genomic sequence analysis of the mouse and human microtubule-associated protein tau.

Authors:  P Poorkaj; A Kas; I D'Souza; Y Zhou; Q Pham; M Stone; M V Olson; G D Schellenberg
Journal:  Mamm Genome       Date:  2001-09       Impact factor: 2.957

Review 3.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

4.  Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro.

Authors:  M Pizzi; A Valerio; M Belloni; V Arrighi; A Alberici; P Liberini; P Spano; M Memo
Journal:  Brain Res Mol Brain Res       Date:  1995-12-01

5.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

6.  The microtubule binding domain of tau protein.

Authors:  G Lee; R L Neve; K S Kosik
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau.

Authors:  D Panda; B L Goode; S C Feinstein; L Wilson
Journal:  Biochemistry       Date:  1995-09-05       Impact factor: 3.162

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  3 in total

1.  Age-related changes in tau expression in transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Anna Barańczyk-Kuźma; Ewa Usarek; Magdalena Kuźma-Kozakiewcz; Beata Kaźmierczak; Beata Gajewska; Birgit Schwalenstocker; Albert C Ludolph
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

2.  Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease.

Authors:  Magdalena Kuźma-Kozakiewicz; Ewa Usarek; Albert C Ludolph; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2011-03-06       Impact factor: 3.996

3.  Dynactin Deficiency in the CNS of Humans with Sporadic ALS and Mice with Genetically Determined Motor Neuron Degeneration.

Authors:  Magdalena Kuźma-Kozakiewicz; Agnieszka Chudy; Beata Kaźmierczak; Dorota Dziewulska; Ewa Usarek; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2013-09-28       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.